durvalumab tolerability in non–small cell lung cancer
Published 4 years ago • 878 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
5:13
effectively managing treatment with durvalumab
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
4:12
treatment process in non–small cell lung cancer
-
5:28
durvalumab consolidation in nsclc: the pacific trial
-
3:07
the use of durvalumab in locally advanced nsclc
-
1:37
results for durvalumab in the second-line treatment of nsclc
-
1:28
durvalumab as a consolidation therapy for locally advanced nsclc
-
6:06
stage iii nsclc: when to start durvalumab
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
2:26
durvalumab following chemoradiotherapy and surgery
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
1:01
impact of durvalumab as consolidation therapy in nsclc
-
5:53
targeted therapy in non-small cell lung cancer
-
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
2:12
safir 02: durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer
-
0:52
genomic testing is necessary in non-small cell lung cancer
-
6:50
implications for using durvalumab in stage 3 nsclc
-
3:22
locally advanced nsclc: durvalumab and the pacific trial
-
3:16
phase 1b trial of durvalumab plus tremelimumab for advanced non-small cell lung cancer